Zydus Receives USFDA Orphan Drug Status for Usnoflast
Ahmedabad, India, January 23, 2025 Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor,…